Sagimet Biosciences Inc. (SGMT)

NASDAQ: SGMT · Real-Time Price · USD

7.61

-0.45 (-5.58%)

At close: Nov 4, 2025, 4:00 PM EST

7.65

+0.04 (0.53%)

After-hours: Nov 4, 2025, 6:08 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Therapeutics for the Treatment of Metabolic Dysfunction-associated Steatohepatitis and Other Diseases	2.00M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	2.00M